3 Takeaways From Aphria Inc’s (TSX:APHA) Q3 Results

Aphria Inc (TSX:APHA)(NYSE:APHA) disappointed investors with its latest quarterly results, but is the stock still a good buy?

edit Businessman using calculator next to laptop

Image source: Getty Images.

Aphria (TSX:APHA)(NYSE:APHA) released its third-quarter results on Monday. The company’s revenues were up more than 600% in what was its first quarter with a full three months of recreational sales. However, with Aphria recording a loss of more than $108 million, investors were left unimpressed, as the stock dropped 14% on the day the results were announced.

It was a bit of a mixed bag of results for the company, but here are three things that stood out to me in Aphria’s latest quarterly results.

Costs to produce cannabis are rising

Aphria has long positioned itself as a low-cost producer. And yet, during this past quarter, it saw its costs continue to rise. In Q3, costs to produce dried cannabis per gram were $1.48, which is up 10% from Q2 when costs were just $1.34. And if we look at “all-in” costs per gram, that also rose from $2.60 in Q2 to $3.76 for an increase of 45%.

With rising per-gram costs, it’s no wonder that Aphria’s gross margins before fair-value adjustments were just 18%. That’s a very low margin, and if that continues it’s only going to get more difficult for Aphria to stay out of the red.

LATAM assets were significantly overvalued

Last year, we heard about short-sellers being critical of Aphria’s LATAM assets and that they were heavily overvalued. Well, on Monday, we got confirmation of just that as the company had write-downs of $50 million relating to those assets.

For investors, it’s troubling because it calls into question Aphria’s decision making and whether management is making good acquisitions or not. Certainly, in this case, it doesn’t look good and might have investors second-guessing Aphria next time the company makes a big acquisition or investment.

Company is still nowhere near breakeven

Even if we take out the $58 million that Aphria incurred in impairment charges this past quarter, it still wouldn’t be nearly enough to pull the company out of the red. There’s, unfortunately, no shortage of issues plaguing the company and preventing it from being profitable. Low margins, rising operating expenses, and losses from non-operating items are some of the areas that need to be addressed before investors can have any real expectation that Aphria will be profitable.

Bottom line

Aphria achieved strong sales growth but not much else in its latest quarter. And while sales growth has been enough for marijuana stocks thus far, investors made it clear that that isn’t the case anymore. Otherwise, we would have seen the stock jump on earnings rather than crash.

Investors are paying some big premiums to own marijuana stocks; without some more substance behind them, it’s only going to become more difficult to justify keeping the stocks. Aphria has typically lagged behind some of its bigger competitors in the industry, and while it’s been off to a great start to 2019, these results may bring the bears back out.

And with no permanent replacement yet for Vic Neufeld, there’s still a lot of risk and uncertainty surrounding the company today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Upwards momentum
Energy Stocks

3 Canadian Stocks That Could be Huge Winners in the Next Decade and Beyond

Stocks like Canopy Growth, Blackberry, and Ballard Power are leading and redefining new multi-billion dollar industries.

Read more »

A cannabis plant grows.
Cannabis Stocks

Should You Invest in Canadian Cannabis Stocks Like Canopy Growth in September?

Canadian cannabis stocks, including Canopy Growth, remain high-risk bets for investors, despite trading 94% below all-time highs.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

ACB Stock: What’s Behind Aurora Cannabis’ Recent Surge?

More countries are legalizing marijuana. Should you buy ACB stock?

Read more »

data analytics, chart and graph icons with female hands typing on laptop in background
Cannabis Stocks

Got $5,000? 3 Stocks to Hold for the Next 20 Years

Long-term investors can consider buying shares of Dollarama and Curaleaf to generate market-beating gains in the next two decades.

Read more »

A cannabis plant grows.
Cannabis Stocks

Is Now the Time to Buy Cannabis Stocks?

These cannabis stocks are up 70% and 19% this month! Should Canadian investors hop on board?

Read more »

A cannabis plant grows.
Cannabis Stocks

Why I’m Considering Canopy Growth Stock For My RRSP

As the cannabis industry grows, adding Canopy Growth stock to my RRSP will give me access to massive upside.

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock Jumps 20%: Here’s What Happened

Canopy Growth stock (TSX:WEED)(NASDAQ:CGC) popped 20% on Monday from an announcement made by another cannabis producer.

Read more »

Retirement plan
Dividend Stocks

4 Stocks That Could Turn $100,000 Into $500,000 by the Time You Retire

Companies such as Brookfield Asset Management have the potential to consistently beat the broader markets and deliver stellar returns to…

Read more »